XML 42 R28.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Stockholders' Equity Note [Abstract] |
Schedule of Common Stock Shares Reserved For Future Issuance | Shares of authorized but unissued common stock reserved for future issuance were as follows (in thousands):
| December 31, 2023 |  | December 31, 2022
Stock options issued and outstanding | 218 |  |  | 226 |
Restricted stock units issued and outstanding | 3,105 |  |  | 2,238 |
Performance-based stock units issued and outstanding | 400 |  |  | 242 |
Shares available for grant | 2,810 |  |  | 5,165 |
Total shares reserved | 6,533 |  |  | 7,871 |
Schedule of Stock Option Share Activity Under Stock Plans | The following table summarizes activity under our A&R 2014 Plan and A&R 2021 Inducement Plan for the year ended December 31, 2023 (in thousands):
Balance at December 31, 2022(1) | 5,165 |
Restricted stock units granted | (2,413) |
Performance-based stock units granted | (337) |
Restricted stock units cancelled | 283 |
Performance-based stock units cancelled | 104 |
Options cancelled | 8 |
Balance at December 31, 2023 | 2,810 |
_______ (1)Shares available for grant do not include treasury stock shares that could be granted if we determined to do so.
Schedule of Stock-Based Compensation Expense By Award Type | The following table summarizes stock-based compensation expense recognized for the years presented below (in thousands):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Restricted stock units | $ | 19,151 |  |  | $ | 17,837 |  |  | $ | 23,645 |
Performance-based stock units | 2,422 |  |  | 876 |  |  | 6,867 |
Common stock options | 1,254 |  |  | 1,154 |  |  | 707 |
Employee stock purchase program | 386 |  |  | 449 |  |  | 1,638 |
Total stock-based compensation expense | $ | 23,213 |  |  | $ | 20,316 |  |  | $ | 32,857 |
Related tax benefit recognized | $ | 5,488 |  |  | $ | 4,747 |  |  | $ | 7,746 |
Schedule of Stock-Based Compensation Expense By Operating Function | The following table summarizes stock-based compensation expense by operating function for the years presented below (in thousands):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Marketing and advertising | $ | 2,201 |  |  | $ | 1,901 |  |  | $ | 8,660 |
Customer care and enrollment | 2,287 |  |  | 2,096 |  |  | 2,836 |
Technology and content | 4,498 |  |  | 6,015 |  |  | 10,013 |
General and administrative | 14,227 |  |  | 10,304 |  |  | 11,348 |
Total stock-based compensation expense | 23,213 |  |  | 20,316 |  |  | 32,857 |
Amount capitalized for internal-use software | 1,040 |  |  | 1,885 |  |  | 2,621 |
Total stock-based compensation | $ | 24,253 |  |  | $ | 22,201 |  |  | $ | 35,478 |
Schedule of Activity Under Stock Plans | The following table summarizes stock option activity (in thousands, except weighted-average exercise price and weighted-average remaining contractual life data):
| Number of Stock Options (1) |  | Weighted Average Exercise Price |  | Weighted-Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value (2)
Outstanding as of December 31, 2022 | 226 |  |  | $ | 39.07 |  |  | 5.3 |  | $ | — |
Granted | — |  |  | $ | — |  |  |  |  |
Exercised | — |  |  |  |  |  |  |
Forfeited | (8) |  |  | $ | 23.34 |  |  |  |  |
Outstanding balance as of December 31, 2023 | 218 |  |  | $ | 39.65 |  |  | 4.5 |  | $ | — |
Vested and expected to vest as of December 31, 2023 | 194 |  |  | $ | 39.48 |  |  | 4.5 |  | $ | — |
Exercisable as of December 31, 2023 | 74 |  |  | $ | 36.98 |  |  | 4.0 |  | $ | — |
_______ (1)Includes certain stock options with service, performance-based or market-based vesting criteria. (2)The aggregate intrinsic value is calculated as the product between eHealth’s closing stock price as of December 31, 2023 and 2022 and the exercise price of in-the-money options as of those dates. The following table provides information pertaining to our stock options for the years presented below (in thousands, except weighted-average fair values):
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Weighted average fair value of options granted | n/a |  | n/a |  | $ | 41.03 |
Total fair value of options vested | $ | 534 |  |  | $ | 835 |  |  | $ | 797 |
Intrinsic value of options exercised | n/a |  | $ | 694 |  |  | $ | 5,182 |
Schedule of Fair Value Of Stock Options Granted, Valuation Assumptions | For the options granted during the year ended December 31, 2021, the fair value of stock options granted to employees was estimated using the Black-Scholes option-pricing model and with the following weighted average assumptions for the year presented below:
| Year Ended December 31,
| 2021
Expected term (years) | 7.0
Expected volatility | 69.1%
Expected dividend yield | —%
Risk-free interest rate | 1.3%
Schedule of Restricted Stock Unit Activity Under Stock Plans | The following table summarizes restricted stock unit activity (in thousands, except weighted-average grant date fair value and weighted-average remaining service period data):
| Number of Restricted Stock Units |  | Weighted-Average Grant Date Fair Value |  | Weighted-Average Remaining Service Period (years) |  | Aggregate Intrinsic Value (1)
Outstanding as of December 31, 2022 | 2,238 |  |  | $ | 19.13 |  |  | 1.4 |  | $ | 10,832 |
Granted | 2,413 |  |  | $ | 8.33 |  |  |  |  |
Vested | (1,263) |  |  | $ | 16.88 |  |  |  |  |
Forfeited | (283) |  |  | $ | 22.80 |  |  |  |  |
Outstanding as of December 31, 2023 | 3,105 |  |  | $ | 11.31 |  |  | 1.3 |  | $ | 27,083 |
_______ (1)The aggregate intrinsic value is calculated as the difference of the grant date price and our closing stock price as of December 31, 2023 and 2022 multiplied by the number of restricted stock units outstanding as of December 31, 2023 and 2022, respectively.
Schedule of Performance-Based Stock Units | The following table summarizes performance-based stock unit activity (in thousands, except weighted-average grant date fair value and weighted-average remaining service period data):
| Number of Performance-based Stock Units |  | Weighted-Average Grant Date Fair Value |  | Weighted-Average Remaining Service Period (years) |  | Aggregate Intrinsic Value (1)
Outstanding as of December 31, 2022 | 242 |  |  | $ | 20.55 |  |  | 1.1 |  | $ | 1,172 |
Granted | 337 |  |  | $ | 7.56 |  |  |  |  |
Vested | (75) |  |  | $ | 4.42 |  |  |  |  |
Forfeited | (104) |  |  | $ | 14.08 |  |  |  |  |
Outstanding as of December 31, 2023 | 400 |  |  | $ | 14.32 |  |  | 0.6 |  | $ | 3,486 |
_______ (1)The aggregate intrinsic value is calculated as the difference of the grant date price and our closing stock price as of December 31, 2023 and 2022 multiplied by the number of performance stock units outstanding as of December 31, 2023 and 2022, respectively.
Schedule of Restricted Stock Units, Valuation Assumptions | The weighted-average fair value of the market-based restricted stock units was determined using the Monte Carlo simulation model using the following weighted average assumptions:
| Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Expected term (years) | 1.1 |  | 2.1 |  | 2.0
Expected volatility | 76.3% |  | 68.7% |  | 66.0%
Expected dividend yield | —% |  | —% |  | —%
Risk-free interest rate | 4.0% |  | 2.5% |  | 0.9%
Weighted-average grant date fair value | $4.79 |  | $9.66 |  | $46.36

X
- Definition Common Stock Shares Reserved For Future Issuance + References No definition available. + Details
Name: | ehth_CommonStockSharesReservedForFutureIssuanceTableTextBlock
Namespace Prefix: | ehth_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions + References No definition available. + Details
Name: | ehth_ScheduleOfShareBasedPaymentAwardRestrictedStockUnitsValuationAssumptionsTableTextBlock
Namespace Prefix: | ehth_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block] + References No definition available. + Details
Name: | ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock
Namespace Prefix: | ehth_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Stock-Based Compensation Expense [Table Text Block] + References No definition available. + Details
Name: | ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock
Namespace Prefix: | ehth_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Stock Option Share Activity Under Stock Plans + References No definition available. + Details
Name: | ehth_ScheduleOfStockOptionShareActivityUnderStockPlansTableTextBlock
Namespace Prefix: | ehth_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration